The Largest VC Firms in Cyprus
Leading venture capital firms in Cyprus, ranked by reported assets under management (AUM). Discover the most active local VCs and unlock full profiles to reach out.
Capital Landscape
Cyprus occupies a distinctive position in Southern Europe's venture ecosystem, but it does not carry the AUM concentration of larger Mediterranean hubs like Israel or the continental capitals. The market remains relatively small in absolute terms, with total institutional venture capital managed out of Cyprus likely sitting in the low-to-mid single-digit billions when aggregated across all active vehicles, a figure that reflects the island's size and its historical role as a financial services and holding-company jurisdiction rather than a primary startup origination market.
What complicates simple AUM comparisons is Cyprus's dual character. A portion of funds legally domiciled or managed through Cyprus are not exclusively Cyprus-focused in their mandate; they often deploy across Central and Eastern Europe, the Balkans, or the broader MENA corridor, using Cyprus as a structuring base because of its EU membership, favorable tax treaties, and familiar common-law legal framework. This means headline AUM figures overstate the capital actually available to Cypriot startups specifically.
Compared to peers of similar population and GDP in Southern Europe, Cyprus punches above its weight in terms of fund formation activity, partly because the infrastructure for fund administration, legal structuring, and banking relationships is well-developed relative to the island's economic size. Greece, for instance, has a larger domestic startup base but a comparably thin institutional venture layer. Cyprus benefits from proximity to Israeli deal flow and has seen increasing interest from diaspora capital networks. The market is still maturing, early-stage ticket sizes from locally anchored funds tend to be smaller than Western European equivalents, and exit liquidity through local public markets is limited, which shapes how funds here structure their timelines and return expectations.
Notable Fund Archetypes
These funds use Cyprus as a base to invest across Southeastern Europe and occasionally into MENA or Israel. They are stage-flexible, typically leading seed to Series A rounds, and their geographic mandate is broader than any single country thesis.
Anchored in Cyprus for structural reasons but operationally focused on Central and Eastern European deal flow, these funds target pre-seed and seed companies in underserved regional markets. Ticket sizes tend to be modest, often below one million euros at entry, with reserves for follow-on.
Given Cyprus's long history as a financial services jurisdiction, a category of sector-specific vehicles has emerged focused on fintech, payments, and financial infrastructure. These funds leverage local regulatory familiarity and banking relationships to source and support portfolio companies in regulated industries.
Cyprus's active property sector and significant foreign investment in real estate have created a niche for funds that blend traditional property assets with technology-enabled real estate businesses. These vehicles often sit at the intersection of private equity and venture, with longer hold periods than pure venture funds.
A meaningful share of Cypriot venture activity is driven by high-net-worth diaspora capital and family offices that have formalized their investment activity into fund structures. These vehicles are typically smaller, more relationship-driven, and tend to co-invest alongside institutional leads rather than lead rounds independently.
Funds partially capitalized through European Investment Fund programs or similar EU instruments operate in Cyprus, often with a mandate to crowd in private capital into early-stage companies. They carry specific eligibility criteria for portfolio companies and often require co-investors to share governance responsibilities.
How to Approach These Funds
Founders targeting larger funds operating out of or through Cyprus should understand that these vehicles often have a regional rather than purely domestic mandate. The pitch framing matters: positioning your company as relevant to Southeastern Europe, the Eastern Mediterranean, or a cross-border corridor will land better than a purely Cyprus-domestic story, unless the local market itself is the specific thesis.
Warm introductions carry more weight here than cold outreach, and this is not just a cultural preference. The Cyprus investment community is genuinely small. General partners tend to know each other, share deal flow, and maintain active relationships with a relatively contained set of lawyers, accelerator operators, and angels. Getting introduced through a trusted node in that network compresses the trust-building process considerably. Portfolio founders from a target fund's existing companies are often the highest-value introduction path.
Stage fit deserves careful attention. Funds anchored here that have significant AUM are often investing at seed through Series A, but the definition of those stages can vary from Western European norms. A fund managing several hundred million euros across a regional mandate may still write initial checks in the low hundreds of thousands, with a strategy of leading or co-leading at later rounds once conviction is established. Asking directly about check size ranges and ownership targets in a first meeting is expected and practical, not presumptuous.
Due diligence processes at Cypriot-based funds tend to be thorough on legal structure and jurisdiction questions, given the complexity of holding companies, IP ownership, and cross-border employment that characterizes many regional startups. Having clean corporate documentation, clear IP assignment, and a well-understood cap table before entering conversations will save time. Funds here have seen many companies with messy offshore structures and they will flag it early.
Top VC firms in Cyprus
216 VC firms with reported AUM. Sign up to unlock full profiles.
| # | VC Firm | AUM |
|---|---|---|
| 1 | EQT Holdings AB EQT is a global investment organization focused on active ownership and thematic investing across private capital, infrastructure, and real estate, from early-stage ventures to large-cap buyouts. | |
| 2 | Silicon Valley Bank Silicon Valley Bank (SVB) is a specialized financial partner for the innovation economy, serving startups from pre-seed to IPO, as well as venture capital and private equity investors globally. | |
| 3 | ![]() Novo Holdings Novo Holdings A/S is the holding and investment company responsible for managing the assets of the Novo Nordisk Foundation, one of the world's largest enterprise foundations. Established in 1999, the company is headquartered in Copenhagen, Denmark, with offices in London, San Francisco, Boston, Singapore, and Shanghai. As of 2024, Novo Holdings manages total assets of DKK 1,060 billion (€142 billion).
The company's primary objective is to improve people's health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation.
To achieve this, Novo Holdings invests in life science companies at all stages of development and manages a diversified portfolio that includes equities, bonds, real estate, infrastructure assets, and private equity investments.
In 2024, Novo Holdings reported record total income and investment returns of DKK 60 billion (€8.0 billion), driven by strong performances from its investment portfolio and the Novo Group companies.
A significant recent development was the completion of a $16.5 billion acquisition of Catalent, a contract drug manufacturer, in December 2024. This strategic move aims to bolster the production of Wegovy, a popular weight-loss drug, to meet increasing demand.
Novo Holdings' investment areas include life science investments, capital investments, and planetary health investments, with a focus on regions such as North America, Europe, and Asia.
The company's guiding principles emphasize high performance with respect and responsibility, an ambitious strategy focused on return-driven investments, and excellence in operations, including talent development and strong governance. | |
| 4 | ![]() Advent Life Sciences Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA. We are a highly experienced team with a long-standing track record of entrepreneurial and inve stment success through turning break-through science into approved medicines or medical products. We start and invest in early and mid-stage companies with a first-in-class or best-in-class approach. Our investments are focussed in new drug discovery - small molecules, biologics and new modalities - med tech, enabling technologies and vaccines. | |
| 5 | Criteria Venture Tech Criteria Venture Tech is a multi-stage Venture Capital fund, committed to propelling the future of technology. Our mission is to partner with visionary companies that are at the forefront of technological innovation.
We invest in tech companies in Europe and North America, with special focus in Spain and Portugal. We invest agnostically across various stages and verticals, with a specific focus on B2B SaaS and Deeptech, paying particular attention to key areas such as Software Infrastructure, Enterprise Data and Automation, Frontier Tech and Cybersecurity, offering evergreen support until achieving meaningful impact. We believe in creating long-term economic and social value through technological breakthroughs.
Criteria Venture Tech is part of Caixa Capital Risc and the CriteriaCaixa group, Spain's largest investment holding with over €25 billion in assets under management. | |
| 6 | ![]() TenOneTen Ventures TenOneTen Ventures is a Los Angeles-based venture capital firm that invests early in technical teams transforming major industries like healthcare, logistics, and manufacturing using AI and data. | |
| 7 | ![]() BAM Ventures BAM Ventures is a Los Angeles-based venture capital firm founded in 2014 by Brian Lee and Richard Jun, both seasoned entrepreneurs with extensive experience in building and scaling companies. The firm focuses on early-stage investments, targeting resilient founders who have the vision to launch and scale innovative technologies, products, and services that connect with consumers and transform commerce. BAM Ventures emphasizes a hands-on approach, offering not only capital but also time, experience, and relationships to support entrepreneurs in building companies that matter.
Their portfolio includes notable companies such as Honey (acquired by PayPal), Tala, Wondery (acquired by Amazon), Flow, Rael, and Modern Animal. | |
| 8 | BEKA Finance, Sociedad de Valores, S.A. Beka AM and theFoodTechLab seal a partnership for the launch of funds aimed at early-stage companies in the agri-food sector, fostering a more sustainable and efficient production, reducing the environmental impact and optimizing the use of resources, through disruptive technologies and scalable B2B models aimed at achieving a global impact . We prioritize sectors and regions with high growth potential, using rigorous and unique due diligence and analysis to identify promising investments. | |
| 9 | Lightspeed Venture Partners Lightspeed Venture Partners is a multi-stage venture capital firm focused on accelerating disruptive innovations and trends in the Enterprise, Consumer, and Health sectors. Over the past two decades, the Lightspeed team has backed hundreds of entrepreneurs and helped build more than 400 companies globally, including Snap, Affirm, Nest, Nutanix, AppDynamics, MuleSoft, OYO, Guardant, and GrubHub. Lightspeed and its affiliates currently manage $10.5B across the global Lightspeed platform, with investment professionals and advisors in Silicon Valley, Israel, India, China, Southeast Asia and Europe. | |
| 10 | ![]() SWEN Capital Partners SWEN Capital Partners is a leading responsible investor in unlisted assets with over €9.5 billion under management. They focus on sustainable finance, supporting environmental and societal growth across private equity, real assets (infrastructure), and private debt. | |
| 11 | Invus Invus is an evergreen equity investment firm founded in 1985, managing over $10 billion in capital. With offices in New York, Paris, and Hong Kong, Invus focuses on empowering owner-managers to transform their industries by providing the freedom to take risks, the capital to reach their goals, and the strategic advice to navigate uncharted waters. The firm emphasizes a long-term investment horizon, aiming for exponential, sustainable value creation through building sustainable competitive advantages and innovating to fulfill real customer needs.
Invus operates with a unique structure that allows flexibility in the types of companies and situations they engage with, fully aligning their incentives with their partners and demonstrating a long-term commitment to see through any challenges along the way. Since its inception, Invus has been successfully empowering owner-managers, with its source of capital being a European family group through their Artal investment vehicle. This evergreen structure has enabled Invus to compound its initial pool of capital over four decades, growing to over $10 billion even after distributing billions to shareholders. | |
| 12 | a16z crypto a16z crypto is a venture capital fund that invests in crypto and blockchain startups. It recently raised a new $2.2 billion fund, bringing its total raised to date to $9.8 billion. | |
| 13 | ![]() Perceptive Advisors Perceptive is focused on supporting the progress of the life sciences industry by identifying opportunities and directing financial resources to the most promising technologies in healthcare.The information presented in this page is included to enable professional networking by Perceptive Advisor’s employees and should not be used for any other purpose. As such, Perceptive Advisor’s use of LinkedIn is not an offer to, or solicitation of, any potential clients or investors for the provision of investment management, advisory or any other related services. No information posted by Perceptive Advisors should be construed as investment advice, or as an offer to sell, or a solicitation of an offer to buy, any security or other instrument. | |
| 14 | Norwest Venture Partners Norwest Venture Partners is a leading Silicon-Valley based venture capital and growth equity investment firm managing $7.5 billion in capital. Since our inception, we have invested in more than 600 companies. The firm invests in early to late stage companies across a wide range of sectors with a focus on consumer, enterprise, and healthcare.We offer a deep network of connections, operating experience, and a wide range of impactful services to help CEOs and founders advance on their journey.We are proud to have backed entrepreneurs at Apigee, Casper, FireEye, Jet, Kendra Scott, and Udemy among others.Norwest has offices in Palo Alto and San Francisco, with subsidiaries in Mumbai and Bengaluru, India and Herzelia, Israel. | |
| 15 | ![]() Vertex Venture Holdings Vertex is a global network of venture capital funds. The Vertex network of funds invests in early stage opportunities in technology through Vertex Ventures and healthcare through Vertex Ventures HC, and growth stage opportunities through Vertex Growth. Each of the Vertex Ventures funds in Israel, USA, China, and SEA & India operate independently, with separate local teams that raise and manage respective funds independently.Vertex Holdings is an anchor investor in each of the Vertex funds, namely: Vertex Ventures China, Vertex Ventures USA, Vertex Ventures Israel, Vertex Ventures SEA & India, Vertex Ventures HC, and Vertex Growth. Vertex Holdings is owned by Temasek Holdings. | |
| 16 | Canaan Partners Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas. While we love speedy success, we're acutely aware that greatness comes in many forms and at different times. That's why we're not afraid to break the mold to bring something spectacular to life.
Our approach is personal.
We don’t believe in a one-size-fits-all approach, but there are a few absolutes intrinsic to who we are and how we work. And these values weren’t contrived out of thin air, they’re hard earned over the past 30 years and counting.
01
High performance, low ego.
The old adage “actions speak louder than words” rings true within Canaan’s walls, and in our interactions with companies out in the wild. Words like "understated" and "effective" are often used to describe our partners, and that’s fine by us. We’ll leave the bragging to the others.
“Seasoned investors can be very arrogant, but Canaan is no BS, unassuming, and humble—no hysteria, no angst.”
— Michael Gilman, CEO Arrakis
02
People are more than statistics.
A diverse team means we bring varied perspectives to the table. And that table welcomes out-of-the-box thinking, spirited debate, and people from all walks of life. It’s our individual backgrounds and interests that inform our collective approach, which spans industries, generations, and coasts. In short, our diversity is who we are and what we do.
03
We ask for help, and so should you.
We firmly believe that two heads are better than one. So while our investors thrive in 1:1 partnerships, our companies also have the support of the entire Canaan team whenever, wherever. Recruiting your executive team? We’ll mobilize our full network. Need operational advice to bring a product to market? We’ll connect you with the right partner or colleague. Our resources are yours.
“Even if Canaan hadn’t funded us, just going through the process with them – the discussions we had and the questions they asked – already made us a better company. And that’s amazing.”
— Julie Wainwright, CEO The RealReal
04
The Golden Rule still applies.
We treat you like we treat ourselves—with respect, transparency, and honesty—even if it’s sometimes not what you want to hear. It’s this approach that makes our portfolio companies more like family, because we’re not afraid to get in the weeds and help solve big hairy problems. In fact, it’s what we live for. We’re acutely aware that our success hinges on your success, so we do what it takes.
“We made big strategic shifts as a company and worked closely with Maha through all of them. Canaan is really smart about the way they get involved and how they support you through good times and bad.”
— Kevin Chou, former CEO Kabam
05
We're in the know, not in the way.
We’d be lying if we said we weren’t hands-on, but we also know when to step back and let you soar. Our goal is to add value to your process, and help you grow in ways you couldn’t alone. That’s why you’ll never see us booking meetings just to check a box or “see how are things are going.” We’ll already know, because that’s the kind of relationship we have with our companies.
Balance, diversity and passion are at the core of who we are. Meet the hardworking people who defy convention, shatter glass ceilings, and take companies to the top — all with a unique style and a healthy dose of humor. | |
| 17 | ![]() 8VC 8VC is a technology and life sciences venture capital firm that builds and invests in transformative companies across various sectors, including life sciences, healthcare, manufacturing, enterprise, logistics, and defense. Founded in 2015 by Joe Lonsdale, a co-founder of Palantir Technologies, the firm is headquartered in Austin, Texas, and manages over $6 billion in committed capital. 8VC's mission is to "fix a broken world" by partnering with entrepreneurs to develop innovative solutions to complex global challenges.
The firm invests at all stages of a company's lifecycle, from seed to growth, and also builds companies through its 8VC Build program. Notable portfolio companies include Palantir Technologies, Anduril Industries, and Guardant Health. 8VC's investment philosophy emphasizes long-term value creation and societal impact, focusing on sectors that have the potential to drive significant positive change.
The firm's team comprises experienced professionals with diverse backgrounds in technology, finance, and entrepreneurship, enabling them to provide comprehensive support to their portfolio companies. | |
| 18 | Forbion Forbion is a global venture capital firm dedicated to advancing groundbreaking biotech innovations and sustainable solutions in human health and the bioeconomy, managing over €5bn across 11 funds. | |
| 19 | ![]() Primavera Capital Group Primavera Capital Group is a premier Asia-Pacific-based global investment firm that seeks to develop trusted, lasting partnerships with high-potential growth companies to promote entrepreneurship and fuel innovation. | |
| 20 | ![]() Northgate Capital Group For more 25 years, Northgate has been partnering with leading venture capital companies and managers to provide long-term value and growth for entrepreneurs and clients through direct investments, primaries, and secondaries. | |
| 21 | ![]() Polaris Partners Polaris Partners is a venture capital firm that has collaborated for nearly three decades with talented biotech and healthcare entrepreneurs to build transformational companies. | |
| 22 | Sofinnova Partners Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future.Founded in 1972, Sofinnova Partners is a deeply-established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners has over €4 billion under management. For more information, please visit: www.sofinnovapartners.com | |
| 23 | The Column Group The Column Group (TCG) is a venture capital firm dedicated to fueling scientific innovation in the life sciences industry. Using an edge-to-edge investment model, TCG supports biotechnology companies from inception and company formation through to exit, focusing on breakthrough therapies and deep scientific principles. | |
| 24 | ![]() VantagePoint Capital Partners Established in 1996, VantagePoint Capital Partners is a global venture investor supporting companies from start-up to scale-up with a special focus on energy innovation and efficiency. | |
| 25 | LSP BioVentures EQT Life Sciences, formerly LSP, is one of Europe’s largest and most experienced Life Sciences investors, targeting innovative companies in therapeutics, medical devices, diagnostics, and healthtech. With over 30 years of experience and approximately €3.5 billion raised, they provide capital and strategic guidance to inventors aiming to improve patient lives. |











